Molecular Formula | C15H21N5OSi |
Molar Mass | 315.45 |
Density | 1.20±0.1 g/cm3(Predicted) |
Boling Point | 501.8±50.0 °C(Predicted) |
pKa | 10.87±0.50(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
Use | This product is for scientific research only and shall not be used for other purposes. |
Hazard Symbols | Xn - Harmful |
Risk Codes | 22 - Harmful if swallowed |
Hazard Class | IRRITANT |
Use | 4-(1H-pyrazol-4-yl)-7-((2-(trimethylsilyl) ethoxy)-methyl)-7H-pyrrolo [2,3-D] pyrimidine is an important intermediate for the preparation of janus kinase inhibitor INCB018424. Also used as an intermediate in the Barretinib of Barektinib. |